Innovation

The Saimerak Pharma perceives its goals on the information available from human genes and proteins research to develop new drug molecules and diagnostics.

 

The Saimerak Pharma works towards designing novel diagnostics and small molecules to target the molecular pathways and biomarkers for specific diseases, through the utilization of path-breaking research out-come in the fields of synthetic chemistry, biology and bioinformatics.

 

 

  

Latest News & Events

  • March 13-17, 2016 251st ACS National Meeting & Exposition, San Diego, California.
  • August 21-25, 2016 252nd ACS National Meeting & Exposition, Philadelphia, Pennsylvania.
  • April 2-6, 2017 253rd ACS National Meeting & Exposition, San Francisco, California.
  • August 20-24, 2017 254th ACS National Meeting & Exposition, Washington, DC.